2023/06/01 22:03:21 | |
---|---|
Price | |
38.02 USD | |
Difference | 0.00% (0.00) |
ISIN | US7170811035 |
Symbol | PFE |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 200,717 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 38.01 USD (500) |
Ask (Ask size) | 38.08 USD (800) |
Open | 38.12 USD |
High | 38.21 USD |
Low | 37.70 USD |
Close (prev. day) | 38.02 USD |
VWAP | 38.018579 USD |
Volume (pcs) | 20,244,821 |
Trading volume | 769,685,780.14 |
Number of trades | 130,987 |
Last size | 3,237,124 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2023/06/01 |
![]() |
Global Equity Ratings |
![]() |
2023/05/24 |
![]() |
Global Equity Ratings |
![]() |
2023/05/03 |
![]() |
Global Equity Ratings |
![]() |
2023/04/25 |
![]() |
Global Equity Ratings |
![]() |
2023/03/28 |
![]() |
Global Equity Ratings |
![]() |
2023/06/01 22:03:21 | |
---|---|
Price | |
38.02 USD | |
Difference | 0.00% (0.00) |
ISIN | US7170811035 |
Symbol | PFE |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 200,717 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 38.01 USD (500) |
Ask (Ask size) | 38.08 USD (800) |
Open | 38.12 USD |
High | 38.21 USD |
Low | 37.70 USD |
Close (prev. day) | 38.02 USD |
VWAP | 38.018579 USD |
Volume (pcs) | 20,244,821 |
Trading volume | 769,685,780.14 |
Number of trades | 130,987 |
Last size | 3,237,124 |
6m | 1Y | 3Y | |
Perf (%) | -27.23% | -28.12% | +17.05% |
Perf (abs.) | -13.23 | -13.83 | +5.15 |
Beta | 0.47 | 0.57 | 0.45 |
Volatility | 22.61 | 23.40 | 26.41 |
Ø price 5 days | Ø volume 5 days (pcs.) | 37.82 USD (32,073,007) |
Ø price 30 days | Ø volume 30 days (pcs.) | 38.38 USD (28,086,392) |
Ø price 100 days | Ø volume 100 days (pcs.) | 41.33 USD (24,390,586) |
Ø price 250 days | Ø volume 250 days (pcs.) | 45.70 USD (21,465,481) |
YTD High | date | 51.60 USD (2023/01/06) |
YTD Low | date | 36.17 USD (2023/05/18) |
52 Weeks High | date | 54.93 USD (2022/12/14) |
52 Weeks Low | date | 36.17 USD (2023/05/18) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2023/06/01 | 17:35 | 35.45 EUR | 1.22 | 150 |
Vienna Stock Exchange | 2023/06/01 | 17:32 | 35.45 EUR | 0.00 | 2 |
Tradegate | 2023/06/01 | 22:26 | 35.35 EUR | 1.77 | 273 |
Stuttgart | 2023/06/01 | 21:55 | 35.30 EUR | 0.05 | 10 |
NYSE | 2023/06/01 | 22:03 | 38.02 USD | 769.69 | 130,987 |
Munich | 2023/06/01 | 08:02 | 35.60 EUR | 0.00 | 1 |
London Stock Exchange | 2023/06/01 | 17:35 | 38.00 USD | 0.00 | 15 |
Hanover | 2023/06/01 | 10:05 | 35.80 EUR | 0.01 | 2 |
Hamburg | 2023/06/01 | 11:05 | 35.65 EUR | 0.00 | 3 |
Frankfurt | 2023/06/01 | 21:47 | 35.35 EUR | 0.15 | 19 |
Duesseldorf | 2023/06/01 | 21:01 | 35.20 EUR | 0.00 | 12 |
Berlin | 2023/06/01 | 08:08 | 35.60 EUR | 0.00 | 1 |
BX Swiss | 2023/05/30 | 18:00 | 33.501 CHF | 0.01 | 2 |
PFIZER INC. |
- - |
66 Hudson Boulevard East - 10001-2192 New York |
Telefon: +1-212-733-2323 |
Fax: + |
E-mail: - |
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY. |
Dan Littman | Member of Board of Directors |
Helen Hobbs | Member of Board of Directors |
Scott Gottlieb | Member of Board of Directors |
Susan Desmond-Hellmann | Member of Board of Directors |
Susan Hockfield | Member of Board of Directors |
James Quincey | Member of Board of Directors |
James Smith | Member of Board of Directors |
Joseph Echevarria | Member of Board of Directors |
Ronald Blaylock | Member of Board of Directors |
Shantanu Narayen | Member of Board of Directors |
Suzanne Johnson | Member of Board of Directors |
Albert Bourla | Chairman of Managing Board |
Aida Habtezion | Member of Executive Committee |
Annaliesa Anderson | Member of Executive Committee |
Barbara Dalton | Member of Executive Committee |
Hakan Sakul | Member of Executive Committee |
Jeff Settleman | Member of Executive Committee |
Maria Rivas | Member of Executive Committee |
Mikael Dolsten | Member of Executive Committee |
William Pao | Member of Executive Committee |
Aamir Malik | Member of Executive Committee |
Andy Schmeltz | Member of Executive Committee |
Angela Hwang | Member of Executive Committee |
Bryan Supran | Member of Executive Committee |
Christopher Stevo | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer